If it is profitable it won't be at 3c range.
Platform is still in development/growth phase.
Customer acquisition/pharmacies' penetration are parameters to watch for as it progress.
Deals.
And then potential international expansion.
Ann: Sales Channel Secured with Arrow Pharmaceuticals-MDR.AX, page-7
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $137.8M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 26.0¢ | 23.0¢ | $327.5K | 1.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 52500 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 161863 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |